Published in Medical Letter on the CDC and FDA, March 10th, 2002
This reduction is attributed to increases in efforts to offer voluntary HIV counseling and testing to all pregnant women and the use of Zidovudine prophylaxis during pregnancy for HIV infected women.
To identify opportunities to further reduce perinatal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.